Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,703 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interventions for treating sexual dysfunction in patients with chronic kidney disease.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, Ruospo M, Querques M, Jannini EA, Strippoli GF. Vecchio M, et al. Among authors: johnson dw. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007747. doi: 10.1002/14651858.CD007747.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154382 Review.
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. Navaneethan SD, et al. Among authors: johnson dw. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005019. doi: 10.1002/14651858.CD005019.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4 PMID: 19370615 Updated. Review.
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. Navaneethan SD, et al. Among authors: johnson dw. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007784. doi: 10.1002/14651858.CD007784. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2 PMID: 19370693 Updated. Review.
HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. Navaneethan SD, et al. Among authors: johnson dw. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004289. doi: 10.1002/14651858.CD004289.pub4. Cochrane Database Syst Rev. 2009. PMID: 19588351 Review.
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF. Palmer SC, et al. Among authors: johnson dw. Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24. Ann Intern Med. 2010. PMID: 20439566 Free article. Review.
Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli GF. Vecchio M, et al. Among authors: johnson dw. Clin J Am Soc Nephrol. 2010 Jun;5(6):985-95. doi: 10.2215/CJN.09081209. Epub 2010 May 24. Clin J Am Soc Nephrol. 2010. PMID: 20498250 Free PMC article. Review.
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Strippoli GF; Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE). Strippoli GF, et al. Trials. 2010 Jun 9;11:70. doi: 10.1186/1745-6215-11-70. Trials. 2010. PMID: 20534124 Free PMC article. Clinical Trial.
1,703 results